A Population-Based, Multisite Cohort Study of the Predictors of Chronic Idiopathic Thrombocytopenic Purpura in Children

Institute for Health Research, Kaiser Permanente Colorado, PO Box 378066, Denver, CO 80237-8066, USA.
PEDIATRICS (Impact Factor: 5.47). 03/2008; 121(3):e506-12. DOI: 10.1542/peds.2007-1129
Source: PubMed


The objective of this study was to identify risk factors for developing chronic idiopathic thrombocytopenic purpura in a cohort of pediatric patients with idiopathic thrombocytopenic purpura.
We conducted a retrospective cohort analysis of 259 children who were diagnosed with idiopathic thrombocytopenic purpura between 1991 and 2000 at 1 of 8 managed care organizations that comprise the Vaccine Safety Datalink. We reviewed the charts of 595 potential patients with idiopathic thrombocytopenic purpura from the 8 Vaccine Safety Datalink sites and excluded patients with known causes of thrombocytopenia. Chronic idiopathic thrombocytopenic purpura was defined as having thrombocytopenia for 6 months beyond the initial diagnosis. The risk for developing chronic idiopathic thrombocytopenic purpura was assessed using simple and multivariable analyses.
Of the 259 cases of idiopathic thrombocytopenic purpura, 197 (76%) were acute, 60 (23%) were chronic, and 2 (1%) could not be determined. Among the acute cases, the mean duration of illness was 22 days. There was 1 serious bleeding outcome in the cohort. In multivariable regression analysis, the patients with chronic illness were older, less likely to present with mucosal bleeding, less likely to have had an acute illness before diagnosis, and more likely to present with a platelet count > 20,000/microL than children with acute idiopathic thrombocytopenic purpura. In particular, children whose illness was diagnosed at > or = 10 years of age and who had platelet counts > or = 20,000/microL had an approximate fivefold risk for progressing to chronic disease when compared with children who presented at < or = 2 years of age with platelet counts < 20,000/microL.
Although idiopathic thrombocytopenic purpura tends to be a benign and self-limited condition, acute and chronic idiopathic thrombocytopenic purpura seem to be distinct illnesses defined by age, platelet count, bleeding symptoms, and the presence of acute illness before diagnosis. Physicians should be aware of these differences when advising their patients and families.

Full-text preview

Available from:
  • Source
    • "Here we report a male preponderance among paediatric ITP patients , which is particularly apparent among children 5 years or younger and statistically significant in children aged 2 – 5 years . These findings are in line with earlier reports that boys and girls are equally affected by childhood ITP ( Cohn , 1976 ; Fujimura & Kuramoto , 1992 ; Bolton - Maggs & Moon , 1997 ; Frederiksen & Schmidt , 1999 ; Psaila & Bussel , 2007 ; Feudjo - Tepie et al , 2008 ; Glanz et al , 2008 ; Le Meignen et al , 2008 ; Donato et al , 2009 ) , with evidence of a male predominance in early childhood ITP and male - to - female ratios decreasing from infancy into adolescence ( Kuhne et al , 2000 , 2001 , 2003 ; Sutor et al , 2001 ; Watts , 2004 ; Zeller et al , 2005 ; Segal & Powe , 2006 ; Fogarty & Segal , 2007 ) . However , one large study ( Zeller et al , 2000 ) found a slight female predominance in children of 1AE2 – 1 . "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study assessed the incidence of immune thrombocytopenia (ITP) and characteristics associated with ITP in the paediatric population using the General Practice Research Database (GPRD). Two hundred and fifty-seven paediatric ITP patients were identified out of 1145 incident patients with ITP recorded between 1990 and 2005. The age-specific incidence for ITP in paediatric patients was 4.2 per 100,000 person-years (PY) [95% confidence interval (CI): 3.7-4.8 per 100,000 PY], with a statistically significantly higher incidence in boys compared to girls aged 2-5 years [9.7 (95% CI: 7.5-12.2) per 100,000 PY vs. 4.7 (95% CI: 3.2-6.6) per 100,000 PY, respectively]. By contrast, among teenagers aged 13-17 years, the overall incidence was lower [2.4 (95% CI: 1.7-3.3) per 100,000 PY] with a similar incidence in girls and boys. There was a relationship between age and sex with ITP incidence, suggesting that patterns of disease burden differ among children and teenagers. Evidence of an infection or immunization shortly before ITP diagnosis was apparent in 52 (20.2%) and 22 (8.6%) of the 257 paediatric ITP patients, respectively. Two deaths were observed during the study period. ITP is an important although rarely fatal disease in paediatric patients and its aetiology remains unexplained in the majority of cases.
    British Journal of Haematology 04/2010; 149(6):855-64. DOI:10.1111/j.1365-2141.2010.08176.x · 4.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Amaç: Son 4 yıl içerisinde ITP tanısı almış pediatrik has-talarda başvuru ve klinik özelliklerinin tanımlanması, kli-nik gidişat, tedavi şekli ve komplikasyonların değerlendi-rilmesi; infeksiyon öyküsü, yaş, cinsiyet, tedavi şekli ve başvuru trombosit sayısının kronikleşme ve relaps üzerine etkilerinin belirlenmesi amaçlandı. Gereç ve Yöntem: Ocak 2005-Haziran 2009 tarihleri ara-sında yaşları 4 ay ile 11 yaş arasında (ortalama 64.2±39.9 ay) değişen akut ITP tanısı almış toplam 40 çocuk hasta dosya kayıtlarından geriye dönük olarak değerlendirildi. Bulgular: Sekiz hasta (% 20) kronik ITP geliştirdi. Akut ve kronik ITP grupları arasında cinsiyet, yaş, infeksiyon öyküsü ve trombosit sayısı açısından fark saptanmadı. Relaps 12 hastada (% 30), tanı sonrası ortalama 22±25.8 gün içerisin-de gelişti. Relaps olanların % 66.7'si (8 hasta) kronik ITP geliştirirken, % 33.3'ü (4 hasta) akut İTP olarak değerlen-dirildi. Relaps gözlenmeyen hastaların hiçbirinde kronikleş-me görülmedi. Relaps oranının istatistiksel olarak anlamlı şekilde kronik grupta yüksek olduğu saptandı. Relaps göste-ren grupta tanı sonrası 15. gün trombosit sayısı ortancaları-nın anlamlı olarak düşük olduğu görüldü. Tedavi türünün relaps üzerine etkisinin olmadığı saptandı. Sonuçlar: Tanı sonrası 15. gün trombosit değerinin relaps olacak hastaların belirlenmesinde kullanılabileceği, ancak vaka sayısı kısıtlı olduğundan daha geniş hasta populasyo-nunda yapılacak prospektif çalışmalarda bu sonucun değerlendirilmesinin daha uygun olacağı sonucuna varıl-dı. Anahtar kelimeler: İdiopatik trombositopenik purpura, kortikosteroid, platelet Çocuk Dergisi 2009; 9(4):181-185 Evaluation of Children with Idiopathic Thrombocytopenic Purpura Aim: To describe presenting features and clinical charac-teristics of ITP and evaluate clinical course, treatment modalities, and complications and determine the effects of preceding infection history, age, gender, treatment moda-lity, and admission platelet count on relapse and chronicity in pediatric patients treated over a 4 year period. Material and Method: Forty cases with an age range of 4 months to 11 years (mean 64.2±39.9 months) who were diagnosed with ITP between January 2005 and June 2009 were retrospectively evaluated from medical records. Results: Eight patients (20 %) progressed to chronic ITP. No difference was found between acute and chronic ITP groups with respect to gender, age, preceding viral infecti-on and platelet count. Relapse developed in 12 patients (30 %), after a mean of 22±25.8 days. While 66.7 % (8 pati-ents) of the relapsed cases developed chronic ITP, 33.3 % (4 patients) were evaluated as acute ITP: None of the cases who have not relapsed progressed to chronic ITP. Relapse rate was statistically significantly higher in the chronic group. Median platelet count at day 15 after diagnosis was significantly lower in the relapse group. It was found that treatment modality had no effect on relapse. Conclusions: Although platelet count at day 15 after diag-nosis can be used in determining the patients who will relapse, since the number of cases are limited it is conclu-ded that it would be better to evaluate this result in a prospective study including a larger study population.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The association of biliary atresia (BA) and idiopathic thrombocytopenic purpura (ITP) is extremely rare, with only 2 cases being reported in the literature. This report describes the very rare case of a 1-year-old boy with BA complicated with ITP after cholangitis and the successful steroid treatment of ITP. We review the literature on this type of relationship between BA and ITP and discuss the clinical features of this complication. Furthermore, the possible cause of the onset of ITP complicated with BA was explored in this report.
    Journal of Pediatric Surgery 02/2009; 44(1):e21-3. DOI:10.1016/j.jpedsurg.2008.09.034 · 1.39 Impact Factor
Show more